RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November
Here is a quick look at some of the top-performing Nasdaq stocks in the past month. These companies all have a market cap of more than $500 million and their share prices are more than 40 percent higher than 30 days ago.
Green Mountain Coffee Roasters (NASDAQ: GMCR) shares jumped more than 32 percent in November, mostly after a stronger-than-expected earnings report late in the month. However, that was not enough to recover ground lost in May after the coffee company lowered its guidance. The price-to-earnings (P/E) ratio is less than the industry average. The stock has narrowly outperformed competitor Starbucks (NASDAQ: SBUX) over the past six months.
See also: Bears Squeezed by Green Mountain Beat
Idenix Pharmaceuticals (NASDAQ: IDIX) is more than 45 percent higher than a month ago, yet still well off the multiyear high reached when the stock spiked early in the year. The biotech company saw an analyst's upgrade last week on the potential for a hepatitis drug it has in development. But note that shares sold short represent about 12 percent of the float. And over the past six months, the stock has underperformed Gilead Sciences (NASDAQ: GILD) and Vertex Pharmaceuticals (NASDAQ: VRTX).
Research In Motion (NASDAQ: RIMM) has risen more than 33 percent in the past month, largely due to optimism about the new BlackBerry 10. But the share price is still down more than 25 percent year to date. RIM's return on equity is in the red, and the short interest is nearly 23 percent of the float, the highest it has been this year. While the stock as outperformed competitor Nokia (NYSE: NOK) over the past six months, it has underperformed Apple (NASDAQ: AAPL) in that time.
Retalix (NASDAQ: RTLX), an enterprise software company headquartered in Israel, jumped to a new multiyear high last week after the announcement that NCR (NYSE: NCR) was buying out the company. The transaction is expected to be completed in the first quarter of 2013. The share price is up more than 80 percent year to date. Even with the post-announcement surge, the stock underperformed competitor JDA Software (NYSE: RGC), which is being bought out as well, over the past six months.
Sequenom (NASDAQ: SQNM) shares are trading more than 51 percent higher than 30 days ago, but less than nine percent higher year to date. The San Diego-based diagnostic services company said earlier this month that demand for its test for Down Syndrome and other disorders was growing and could surpass previous guidance. Note that short interest is more than 33 percent of the float. But the long-term EPS growth forecast is more than 27 percent. Over the past six months, the stock has outperformed Ilumina (NASDAQ: ILMN) and Life Technologies (NASDAQ: LIFE).
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.